Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

Literature DB >> 12409058

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

T R Rebbeck¹.

Abstract

Entities: Gene

Mesh：

Year: 2002 PMID： 12409058 DOI： 10.1016/s0959-8049(02)00269-1

Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

1. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.

Authors: Gillian W Hooker; Kara-Grace Leventhal; Tiffani DeMarco; Beth N Peshkin; Clinton Finch; Erica Wahl; Jessica Rispoli Joines; Karen Brown; Heiddis Valdimarsdottir; Marc D Schwartz
Journal: Med Decis Making Date: 2010-09-27 Impact factor: 2.583

Review 2. Susceptibility pathways in Fanconi's anemia and breast cancer.

Authors: Alan D D'Andrea
Journal: N Engl J Med Date: 2010-05-20 Impact factor: 91.245

Review 3. Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy.

Authors: Wen Zhou; Joyce M Slingerland
Journal: Nat Rev Cancer Date: 2014-01 Impact factor: 60.716

Review 4. Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.

Authors: Katherine Stemke-Hale; Bryan Hennessy; Gordon B Mills; Rahul Mitra
Journal: Curr Oncol Rep Date: 2006-11 Impact factor: 5.075

5. Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy.

Authors: Kathleen M Sturgeon; Lorraine T Dean; Mariane Heroux; Jessica Kane; Toni Bauer; Erica Palmer; Jin Long; Shannon Lynch; Linda Jacobs; David B Sarwer; Mary B Leonard; Kathryn Schmitz
Journal: J Cancer Surviv Date: 2016-11-21 Impact factor: 4.442

6. Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia.

Authors: G E Hanley; J N McAlpine; R Cheifetz; K A Schrader; M McCullum; D Huntsman
Journal: Curr Oncol Date: 2019-02-01 Impact factor: 3.677

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

1. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.

Review 2. Susceptibility pathways in Fanconi's anemia and breast cancer.

Review 3. Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy.

Review 4. Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.

5. Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy.

6. Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia.

7. Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.

8. Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.

9. Risk-reduction surgery in BRCA mutation carriers in a Spanish population: adherence and results.

Review 10. Gynecologic cancers associated with Lynch syndrome/HNPCC.